In vivo effects of chicken myelomonocytic growth factor: Delivery via a viral vector

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 2991-2997

  York, Jennifer J ^a   Strom, A David G ^a   Connick, Terri E ^a   McWaters, Peter G ^a   Boyle, David B ^a   Lowenthal, John W ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DIFFERENTIATION ANTIGEN; HEMOPOIETIC GROWTH FACTOR; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIRD DISEASE; CHICKEN; FOWLPOX VIRUS; GENE VECTOR; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MONOCYTE; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BASE SEQUENCE; CHICKENS; DNA, COMPLEMENTARY; FOWLPOX; FOWLPOX VIRUS; GENETIC VECTORS; HEMATOPOIETIC CELL GROWTH FACTORS; MOLECULAR SEQUENCE DATA; MONOCYTES; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS;

EID: 0030584797     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Leutz, A , H. Beug, and T. Graf 1984. Purification and characterization of cMGF. a novel chicken myelomonocytic growth factor. EMBO J. 3:3191.
2. Leutz, A., K. Damm, E. Sterneck, E Kowenz, S Ness, R. Frank, J. Gausepohl, Y.-C E Pan, J. Smart, M Hayman, and T. Graf 1989. Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationships to interleukin 6 and granulocyte colony stimulating factor. EMBO J. 8:175.
3. Ramshaw, I., J. Ruby, A Ramsay, G. Ada. and G. Karupiah. 1992. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo Immunol Rev. 127:157
4. Leong, K. H , A. J. Ramsay, D. B. Boyle, and I. A. Ramshaw. 1994. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J Virol. 68:8125.
5. Braciak, T A., S K. Mittal, F. L. Graham, C D. Richards, and J. Gauldie. 1993 Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes J. Immunol. 151:5145.
6. Xing, Z., T. Braciak, M. Jordana, K. Croitoru, F. L. Graham, and J. Gauldie. 1994. Adenovirus-mediated cytokine gene transfer at tissue sites: overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J. Immunol. 153:4050
7. Boyle, D B , and B E. H. Coupar. 1988 Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Res. 10:343.
8. Taylor, J., R. Weinberg, Y Kawaoka, R. G. Webster, and E. Paoletti. 1988. Protective immunity against avian influenza induced by a fowlpox virus recombinant Vaccine 6:504.
9. Taylor, J , C. Edbauer, A. Rey-Senelonge, J.-F. Bouquet, E. Norton, S. Goebel, P Dexmettre, and E. Paoletti. 1990. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens J. Virol. 64:1441
10. Nazerian, K., L. F. Lee, N. Yanagida, and R. Ogawa. 1992 Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol 66:1409.
11. Prideaux, C T., and D. B. Boyle. 1987. Fowlpox virus polypeptides: sequential appearance and virion associated polypeptides. Arch. Virol. 96:185
12. Silim, A., M A El Azhary, and R. S. Roy. 1982. A simple technique for preparation of chicken-embryo-skin cell cultures. Avion Dis. 26:182.
13. Sambrook, J., E. F. Fritsch, and T Maniatis. 1989 Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, New York.
14. Heine, H.-G , and D B. Boyle. 1993 Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Arch Virol. 131:277
15. Boyle, D. B., and B E. H Coupar. 1988. A dominant selectable marker for the construction of recombinant poxviruses. Gene 65.123.
16. Kumar, S., and D. B. Boyle 1990. A poxvirus bidirectional promoter element with early/late and late functions. Virology 179.151.
17. Prideaux, C. T., S. Kumar, and D. B. Boyle. 1990. Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants. Virus Res. 16:43.
18. Lowenthal, J. W., T. E. Connick, P. G McWaters, and J. J. York. 1994 Development of T cell immune responsiveness in the chicken. Immunol. Cell Biol. 72:115.
19. Natt, M. P., and C A Herrick. 1952. A new blood diluent for counting the erythrocytes and leukocytes of the chicken. Poultry Sci. 31.735.
20. Lowenthal, J. W., M. R. Digby, and J. J. York. 1995. Production of interferon-γ by chicken T cells. J. Interferon Cytokine Res. 15:933.
21. Digby M R., and J. W. Lowenthal. 1995. Cloning and expression of the chicken interferon-7 gene. J. Interferon Cytokine Res. 15.939.
22. Steinkamp, J. A., J. S. Wilson, G. C Saunders, and C. C Stewart. 1982 Phagocytosis flow cytometric quantitation with fluorescent microspheres. Science 215: 64.
23. Oda, T., and H. Maeda 1986. A new simple fluorometric assay for phagocytosis. J. Immunol. Methods 88:175.
24. Andoh, A., Y. Fujiyama, K. Kitoh, K Hodohara, T. Bamba, and S Hosoda. 1991 Flow cytometric assay for phagocytosis of human monocytes mediated via Fc γ-receptors and complement receptor CR1 (CD35) Cytometry 12:677.
25. Chakrabarti, S , K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector. co-expression of β-galactosidase provides visual screening of recombinant virus plaques. Mol Cell. Biol. 5.3403.
26. Koren S., G. R. Kumpel, and W. R. Fleischmann, Jr. 1986. Treatment of mice with macrophage colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta, and gamma interferons. J. Biol. Response Modif. 5:481.
27. Hume, D A., P. Pavh, R. E. Donahue, and I. J. Fidler. 1988. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol. 141:3405
28. Ulich, T. R., J. del Castillo, L. R. Watson, S. Yin, and M. B. Garnick. 1990. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood 75:846.
29. Fujisawa, M., Y. Kobayashi, T. Okabe, F. Takaku, Y. Komatsu, and S Itoh. 1986. Recombinant human granulocyte colony-stimulating factor induces granulocytosis in vivo. Jpn. J. Cancer Res. 77:866.
30. Cohen, A. M., K. M Zsebo, H. Inoue, D. Hines, T. C. Boone, V R. Chazin, L. Isai, T. Ritch, and L. M. Sauza. 1987. In vitro stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl. Acad. Sci. USA 84:2484.
31. Metcalf, D., C. G. Begley, D. J. Wilhamson, E. C. Nice, J De Lamarter, J.-J. Mermod, D. Thatcher, and A. Schmidt 1987. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol 15:1.
32. Siatskas C , P McWaters, M. R Digby, J. W. Lowenthal, and R L Boyd. 1996. In vitro characterisation of a novel avian haemopoietic growth factor derived from stromal cells. Dev. Comp. Immunol. in press.
33. Wing, E J., N. M. Ampel, A. Waheed, and R. K. Shadduck. 1985. Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J. Immunol. 135.2052.
34. Ralph, P., and I. Nakoinz. 1987. Stimulation of macrophage tumoricidal activity by the growth and differentiation factor, CSF-J. Cell. Immunol. 105:270.
35. Mufson, R. A., J. Aghajanian, G. G. Wong, C. Woodhouse, and A C Morgan. 1989. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell. Immunol 119:182.
36. Wang, M., H. Friedman, and J. Y. Djeu 1989. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage CSF, and macrophage CSF. J. Immunol 143:671.
37. Khwaja A , B. Johnson, I E. Addison, K Yong, K Ruthven, S Abramson, and D. C. Lynch. 1991. In vivo effects of macrophage colony-stimulating factor on human monocyte function. Br. J. Haematol. 77:25
38. Heath, A. W., and J. H. L. Playfair. 1992. Cytokines as immunological adjuvants. Vaccine 10.427
39. Hinuma, S., M. Hazama, A Mayumi, and Y. Fujisawa 1991 A novel strategy for converting recombinant viral protein into high immunogenic antigen. FEBS Lett. 288:138.
40. Ho, R J Y., K. T Chong, and T. C. Merigan. 1991 Antiviral activity and dose optimum of recombinant macrophage colony-stimulating factor in herpes simplex genitalis in guinea pigs. J. Immunol. 146:3578.
41. Berkowitz, C , and Y. Becker. 1992 Recombinant interleukin-la, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1 Arch Virol. 124.83.